Developer docs
API playgroundTry for free, no card

Search company profiles

Getz Pharma

Full company profile

uuid000978f

Namestring
Getz Pharma
Legal namestring
Getz Pharma (Private) Limited
Websiteurl
getzpharma.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Getz Pharma (Private) Limited is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer founded in 1995 and operating in 45+ countries with 8,000+ employees. The company develops, manufactures, and markets affordable medicines across 13 therapeutic areas — including cardiometabolic, gastroenterology, hepatology, pulmonology, urology, gynecology, oncology, pediatrics, orthopedics and rheumatology, infectious diseases, neuropsychiatry, general medicine, and nephrology — supported by a portfolio of 140+ developed molecules and 200+ branded generic products ranging from cardiovascular and diabetes therapies to monoclonal antibodies and dry-powder inhalers.

Manufacturing is anchored in Karachi at the LEED Platinum-certified Astola facility (South Asia's first pharma LEED Platinum plant), a dedicated fully segregated Cephalosporin and Carbapenem manufacturing plant, and the main head office in the Korangi Industrial Area. The facilities are GMP-approved by the World Health Organization (WHO Prequalification), the Pharmaceutical Inspection Co-operation Scheme (PIC/S), and the Eurasian Economic Union (EAEU), with ISO/IEC 17025:2017-accredited laboratories, bio-equivalence testing through US-FDA-accredited centers, and a dedicated MedVigi pharmacovigilance program. R&D capabilities span immediate/sustained/controlled-release and enteric-coated tablets, capsules, biologicals and biotech products, metered-dose inhalers, and injectables.

The business model is built on branded generic commercialization through wholly-owned regional subsidiaries and dedicated sales offices in markets including the UAE, Philippines, Nigeria, Kenya, Cambodia, Myanmar, Sri Lanka, Kazakhstan, and Pakistan's domestic market, supplemented by distributor networks into hospitals, clinics, and pharmacies. Recent moves include local biosimilar manufacturing of tirzepatide, semaglutide, and oral semaglutide (Oct 2025), a Daraz e-commerce direct-to-consumer partnership (Aug 2026), and an Estheticare collaboration for medical aesthetics (Nov 2025). The company is led by Executive Chairman Khalid Mahmood and Deputy Managing Director Zeeshan Ahmed, with no disclosed institutional or PE/VC ownership, and operates the MedOne medical education platform and NextLead early-careers program as ecosystem-buildout layers around the core pharma franchise.

Short descriptiontext

Getz Pharma is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer operating in 45+ countries with 8,000+ employees, producing affordable generic and biosimilar medicines across 13 therapeutic areas for emerging markets globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersKarachi, Pakistan
HQ citystring
Karachi
HQ countrystring
Pakistan
HQ regionstring
Asia
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
branded generic pharmaceuticals, pharmaceutical manufacturing, therapeutic medicines, biotech injectables, cardio metabolic drugs
Industry4 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Branded Generic Pharmaceuticals
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Branded Generic Pharmaceuticals
TypeOne Time License
Description

Development, production, and marketing of branded generic medicines across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology.

getzpharma.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Pharmaceutical products - pricing not publicly available
ModelOtherBilling cadenceOther
Notes

Getz Pharma manufactures and markets branded generic medicines. Specific pricing is determined by regulatory requirements and market conditions in each country of operation.

getzpharma.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1MedOne
Description

A dynamic platform uniting medical experts, researchers, and leaders to advance science, shape policy, and drive patient-centered care—especially in low- and middle-income countries. Features specialty forums including International Cardiometabolic Forum, International Urology Meeting, International Forum Infectious Diseases, International Psychiatry Forum, International Gastrointestinal and Hepatology Forum, and Public Health and Policy Forum.

getzpharma.com
+2 more records
Core offering1 text field

Getz Pharma develops, manufactures, and markets branded generic pharmaceutical products across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. Its portfolio includes tablets, capsules, biological/biotech products, metered dose inhalers, dry-powder inhalers, and injectable dosage forms, with more than 140 molecules developed and bio-equivalence testing from US-FDA accredited centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 140+ molecules developed across therapeutic areas
+2 more records
Product overview1 text field

Getz Pharma is an international research-driven, branded generic pharmaceutical company with operations in 45+ countries. The company manufactures and markets high-quality generic medicines across 13 therapeutic segments including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. The portfolio includes over 200 branded generic products ranging from cardiovascular medications (Advant, Rovista, Trevia), diabetes treatments (Basagine, Dafo, Diampa, Sem-O, Sem-P, TIRZEE), anti-infectives, respiratory therapies (Prohaler, Fortide), oncology products (Trastuget), and specialty medicines. The company also operates MedOne, a medical education and collaboration platform hosting specialty forums for healthcare professionals.

Product and service3 records
1TIRZEE (Tirzepatide)
CategoryCardiometabolic / Diabetes and Obesity
Description

Tirzepatide injection (GLP-1 and GIP receptor agonist) for the treatment of type 2 diabetes and obesity.

2Sem-O (Semaglutide)
CategoryCardiometabolic / Diabetes
Description

Semaglutide injection (GLP-1 receptor agonist) for diabetes treatment.

3Sem-P (Semaglutide)
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-08-07
Description

Strategic partnership with Pakistan's leading e-commerce platform for delivery of essential medicines within 24 to 72 hours across Pakistan. Combines Getz Pharma's pharmaceutical expertise with Daraz's digital reach and logistics infrastructure.

2Estheticare
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-11-08
Description

Collaboration for the debut of Tirzepatide in Islamabad, with Dr. Uzair Khan leading the initiative in the medical aesthetics sector in Pakistan.

tribune.com.pk
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint venture for PAK-SEHAT research study - a 10-year nationwide longitudinal study focusing on assessing risk factors for coronary heart disease among young individuals under 40 years of age.

4Faysal Funds
Strategic tierMinorTypeOthers
Description

Collaboration for Financial Literacy Session for employees, providing practical knowledge on managing personal finances and investment opportunities.

getzpharma.com
Strategic tierMinorTypeOthers
Description

Support for Critical Futures Conference 2025 on environmental sustainability and climate resilience in Pakistan, held at IVS Karachi.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Getz Pharma

Branded Generic Pharmaceuticalsgetzpharma.com

Getz Pharma is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer operating in 45+ countries with 8,000+ employees, producing affordable generic and biosimilar medicines across 13 therapeutic areas for emerging markets globally.

What Getz Pharma does

Getz Pharma (Private) Limited is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer founded in 1995 and operating in 45+ countries with 8,000+ employees. The company develops, manufactures, and markets affordable medicines across 13 therapeutic areas — including cardiometabolic, gastroenterology, hepatology, pulmonology, urology, gynecology, oncology, pediatrics, orthopedics and rheumatology, infectious diseases, neuropsychiatry, general medicine, and nephrology — supported by a portfolio of 140+ developed molecules and 200+ branded generic products ranging from cardiovascular and diabetes therapies to monoclonal antibodies and dry-powder inhalers.

Manufacturing is anchored in Karachi at the LEED Platinum-certified Astola facility (South Asia's first pharma LEED Platinum plant), a dedicated fully segregated Cephalosporin and Carbapenem manufacturing plant, and the main head office in the Korangi Industrial Area. The facilities are GMP-approved by the World Health Organization (WHO Prequalification), the Pharmaceutical Inspection Co-operation Scheme (PIC/S), and the Eurasian Economic Union (EAEU), with ISO/IEC 17025:2017-accredited laboratories, bio-equivalence testing through US-FDA-accredited centers, and a dedicated MedVigi pharmacovigilance program. R&D capabilities span immediate/sustained/controlled-release and enteric-coated tablets, capsules, biologicals and biotech products, metered-dose inhalers, and injectables.

The business model is built on branded generic commercialization through wholly-owned regional subsidiaries and dedicated sales offices in markets including the UAE, Philippines, Nigeria, Kenya, Cambodia, Myanmar, Sri Lanka, Kazakhstan, and Pakistan's domestic market, supplemented by distributor networks into hospitals, clinics, and pharmacies. Recent moves include local biosimilar manufacturing of tirzepatide, semaglutide, and oral semaglutide (Oct 2025), a Daraz e-commerce direct-to-consumer partnership (Aug 2026), and an Estheticare collaboration for medical aesthetics (Nov 2025). The company is led by Executive Chairman Khalid Mahmood and Deputy Managing Director Zeeshan Ahmed, with no disclosed institutional or PE/VC ownership, and operates the MedOne medical education platform and NextLead early-careers program as ecosystem-buildout layers around the core pharma franchise.

Getz Pharma firmographics

Firmographics
Name
Getz Pharma
Legal name
Getz Pharma (Private) Limited
Website
https://getzpharma.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Getz Pharma is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer operating in 45+ countries with 8,000+ employees, producing affordable generic and biosimilar medicines across 13 therapeutic areas for emerging markets globally.
Ownership category
akta.pro rank

Getz Pharma industry classification

Industry
Product category
Branded Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Branded generic pharmaceuticals
  • Pharmaceutical manufacturing
  • Therapeutic medicines
  • Biotech injectables
  • Cardio metabolic drugs

Where Getz Pharma is headquartered

Location

Headquarters

HQ city
Karachi
HQ country
Pakistan
HQ region
Asia

Offices11 records

Markets served

Getz Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Branded Generic Pharmaceuticals: Development, production, and marketing of branded generic medicines across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology.

Pricing tiers

ModelBillingPrice
OtherOtherPharmaceutical products - pricing not publicly available

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Getz Pharma product offering

Product offering

Core offering

Getz Pharma develops, manufactures, and markets branded generic pharmaceutical products across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. Its portfolio includes tablets, capsules, biological/biotech products, metered dose inhalers, dry-powder inhalers, and injectable dosage forms, with more than 140 molecules developed and bio-equivalence testing from US-FDA accredited centers.

Product overview

Getz Pharma is an international research-driven, branded generic pharmaceutical company with operations in 45+ countries. The company manufactures and markets high-quality generic medicines across 13 therapeutic segments including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. The portfolio includes over 200 branded generic products ranging from cardiovascular medications (Advant, Rovista, Trevia), diabetes treatments (Basagine, Dafo, Diampa, Sem-O, Sem-P, TIRZEE), anti-infectives, respiratory therapies (Prohaler, Fortide), oncology products (Trastuget), and specialty medicines. The company also operates MedOne, a medical education and collaboration platform hosting specialty forums for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

  • MedOne: A dynamic platform uniting medical experts, researchers, and leaders to advance science, shape policy, and drive patient-centered care—especially in low- and middle-income countries. Features specialty forums including International Cardiometabolic Forum, International Urology Meeting, International Forum Infectious Diseases, International Psychiatry Forum, International Gastrointestinal and Hepatology Forum, and Public Health and Policy Forum.
  • MedVigi
  • NextLead

Products and services

  • TIRZEE (Tirzepatide) Tirzepatide injection (GLP-1 and GIP receptor agonist) for the treatment of type 2 diabetes and obesity.
  • Sem-O (Semaglutide) Semaglutide injection (GLP-1 receptor agonist) for diabetes treatment.
  • Sem-P (Semaglutide)

Quantifiable outcome

  • 140+ molecules developed across therapeutic areas
  • +2 more outcomes

Companies that use Getz Pharma

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Getz Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Getz Pharma partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • DarazcoreChannel Partner/ Reseller/ Distributor · 7 August 2026Strategic partnership with Pakistan's leading e-commerce platform for delivery of essential medicines within 24 to 72 hours across Pakistan. Combines Getz Pharma's pharmaceutical expertise with Daraz's digital reach and logistics infrastructure.
  • EstheticareminorGTM or Marketing Partner · 8 November 2025Collaboration for the debut of Tirzepatide in Islamabad, with Dr. Uzair Khan leading the initiative in the medical aesthetics sector in Pakistan.
  • Tabba Heart InstitutecoreStrategic or Co-development PartnerJoint venture for PAK-SEHAT research study - a 10-year nationwide longitudinal study focusing on assessing risk factors for coronary heart disease among young individuals under 40 years of age.
  • Faysal FundsminorOthersCollaboration for Financial Literacy Session for employees, providing practical knowledge on managing personal finances and investment opportunities.
  • Indus Valley School of Art and Architecture (IVS)minorOthersSupport for Critical Futures Conference 2025 on environmental sustainability and climate resilience in Pakistan, held at IVS Karachi.

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

Getz Pharma competitors and assessment

Company assessment

Market position

Competitive moat6 records

Customer concentration

Getz Pharma social profiles

Digital presence

Getz Pharma compliance and trust

Trust signal

Compliance5 records

Getz Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Getz Pharma leadership team

Management profile

Number of profiles

Profiles8 records

Getz Pharma subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Getz Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Getz Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Getz Pharma

What does Getz Pharma do?

Getz Pharma develops, manufactures, and markets branded generic pharmaceutical products across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. Its portfolio includes tablets, capsules, biological/biotech products, metered dose inhalers, dry-powder inhalers, and injectable dosage forms, with more than 140 molecules developed and bio-equivalence testing from US-FDA accredited centers.

Is Getz Pharma a public or private company?

Getz Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Getz Pharma founded?

Getz Pharma was founded in 1995. It employs 5,001 to 10,000 people.

Where is Getz Pharma based?

Getz Pharma is headquartered in Karachi, Pakistan, in the Asia region.

How does Getz Pharma make money?

One revenue line is on record: branded Generic Pharmaceuticals.

Does Getz Pharma have an API?

No public API is recorded for Getz Pharma.

What industry is Getz Pharma in?

Getz Pharma's product category is Branded Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals